Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014871 |
| CAS No | NA |
| Mol.F. | C12H10N2O3 |
| Mol.Wt. | 230.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014872 |
| CAS No | NA |
| Mol.F. | C9H6N2O2 |
| Mol.Wt. | 174.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014873 |
| CAS No | NA |
| Mol.F. | C14H16N2O5 |
| Mol.Wt. | 292.3 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014874 |
| CAS No | NA |
| Mol.F. | C12H10N2O4 |
| Mol.Wt. | 246.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014875 |
| CAS No | NA |
| Mol.F. | C28H30ClN3O3 |
| Mol.Wt. | 492.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014876 |
| CAS No | NA |
| Mol.F. | C24H27N3O4 |
| Mol.Wt. | 421.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014877 |
| CAS No | 67776-06-1 |
| Mol.F. | C7H12N2O4S |
| Mol.Wt. | 220.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014878 |
| CAS No | NA |
| Mol.F. | C9H8N2O |
| Mol.Wt. | 160.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014879 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O3S |
| Mol.Wt. | 517.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014880 |
| CAS No | NA |
| Mol.F. | C18H19ClN8O2S |
| Mol.Wt. | 446.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014881 |
| CAS No | NA |
| Mol.F. | C16H12Cl2N6O2S |
| Mol.Wt. | 423.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014882 |
| CAS No | 2135905-86-9 |
| Mol.F. | C20H21ClN8O2S |
| Mol.Wt. | 473.0 |
| INV STATUS | In Stock |
| CAT No | SRC-N014883 |
| CAS No | NA |
| Mol.F. | C20H21ClN8O2S |
| Mol.Wt. | 473.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014884 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O4S |
| Mol.Wt. | 533.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014885 |
| CAS No | NA |
| Mol.F. | C25H29ClN8O4S |
| Mol.Wt. | 573.1 |
| INV STATUS | In Stock |
| CAT No | SRC-N014886 |
| CAS No | NA |
| Mol.F. | C25H42N2O19 |
| Mol.Wt. | 674.6 |
| INV STATUS | CUSTOM SYNTHESIS |